Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathology
AbstractCongenital disorders of glycosylation (CDG) are a group of neurogenetic conditions resulting from disruptions in the cellular glycosylation machinery. The majority of CDG patients have compound heterozygous pathogenic variants in the phosphomannomutase 2 (PMM2)gene.
Andrew C. Edmondson +19 more
openaire +1 more source
Investigation of the Clinical and Genetic Spectrum of PMM2-CDG: Insights from a Family with a Novel Variant and Previous Studies. [PDF]
Alagha P +6 more
europepmc +1 more source
Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG)
Stroke-like episodes (SLE) occur in phosphomannomutase deficiency (PMM2-CDG), and may complicate the course of channelopathies related to Familial Hemiplegic Migraine (FHM) caused by mutations in CACNA1A (encoding Ca2.1 channel). The underlying pathomechanisms are unknown.
Izquierdo-Serra, Mercè|| +19 more
openaire +1 more source
Ophthalmological and electrophysiological findings in monozygotic twin sisters with phosphomannomutase 2 deficiency (PMM2-CDG) over a period of 37 years. [PDF]
Van Hees I +3 more
europepmc +1 more source
Clinical and genetic characterization of congenital disorders of glycosylation in 20 Chinese patients. [PDF]
Zhao P +8 more
europepmc +1 more source
Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation. [PDF]
Wang R +23 more
europepmc +1 more source
Establishing an auxin-inducible GFP nanobody-based acute protein knockdown system to mimic hypomorphic mutations during early medaka embryogenesis. [PDF]
Pakari K +7 more
europepmc +1 more source
Suspected Central Adrenal Insufficiency in a Patient with Phosphomannomutase 2-Congenital Disorder of Glycosylation. [PDF]
Ødum SF +3 more
europepmc +1 more source

